Correlation Between Biosyent and Salesforce
Can any of the company-specific risk be diversified away by investing in both Biosyent and Salesforce at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biosyent and Salesforce into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biosyent and SalesforceCom CDR, you can compare the effects of market volatilities on Biosyent and Salesforce and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biosyent with a short position of Salesforce. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biosyent and Salesforce.
Diversification Opportunities for Biosyent and Salesforce
0.6 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Biosyent and Salesforce is 0.6. Overlapping area represents the amount of risk that can be diversified away by holding Biosyent and SalesforceCom CDR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SalesforceCom CDR and Biosyent is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biosyent are associated (or correlated) with Salesforce. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SalesforceCom CDR has no effect on the direction of Biosyent i.e., Biosyent and Salesforce go up and down completely randomly.
Pair Corralation between Biosyent and Salesforce
Given the investment horizon of 90 days Biosyent is expected to generate 1.57 times less return on investment than Salesforce. But when comparing it to its historical volatility, Biosyent is 1.29 times less risky than Salesforce. It trades about 0.06 of its potential returns per unit of risk. SalesforceCom CDR is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest 1,271 in SalesforceCom CDR on October 13, 2024 and sell it today you would earn a total of 1,258 from holding SalesforceCom CDR or generate 98.98% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Biosyent vs. SalesforceCom CDR
Performance |
| Timeline |
| Biosyent |
| SalesforceCom CDR |
Biosyent and Salesforce Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Biosyent and Salesforce
The main advantage of trading using opposite Biosyent and Salesforce positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biosyent position performs unexpectedly, Salesforce can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Salesforce will offset losses from the drop in Salesforce's long position.| Biosyent vs. Cipher Pharmaceuticals | Biosyent vs. Covalon Technologies | Biosyent vs. Knight Therapeutics |
| Salesforce vs. Altair Resources | Salesforce vs. XXIX Metal Corp | Salesforce vs. Hemisphere Energy | Salesforce vs. Canlan Ice Sports |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Complementary Tools
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |